Cinctive Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Cinctive Capital Management's BSX Position: Q2 2026 in Review
Cinctive Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 20,462 shares — an estimated $1.28M sold.
Cinctive Capital Management first reported a position in BSX in Q4 2019 and held it in 19 quarters. The position peaked at $19.8M in Q1 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Cinctive Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Cinctive Capital Management sold 20,462 Boston Scientific shares in Q2 2026, an estimated $1.28M.
- Cinctive Capital Management first reported a position in Boston Scientific in Q4 2019 and held it in 19 quarters.
- Cinctive Capital Management's Boston Scientific position peaked at $19.8M in Q1 2024.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.